# Metformin as Adjuvant to Insulin Therapy in Insulin-resistant Diabetes Mellitus With Pregnancy

> **NCT01915550** · PHASE3 · COMPLETED · sponsor: **Ain Shams University** · enrollment: 90 (actual)

## Conditions studied

- Diabetes Mellitus

## Interventions

- **DRUG:** Metformin
- **DRUG:** Humulin Insulin Mixtard

## Key facts

- **NCT ID:** NCT01915550
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-04
- **Primary completion:** 2013-01
- **Final completion:** 2013-02
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2013-08-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01915550

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01915550, "Metformin as Adjuvant to Insulin Therapy in Insulin-resistant Diabetes Mellitus With Pregnancy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01915550. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*